Bo Chen

发表

Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade

Ting Chen, Yunyan Gu, Yan Xu, 2022, British Journal of Cancer.

A genetic map of the chromatin regulators to drug response in cancer cells

Ting Chen, Yunyan Gu, Min Zou, 2022, Journal of Translational Medicine.

Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer

Xia Li, Yunyan Gu, Lichun Sun, 2021, Oncogene.

Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome

Yunyan Gu, L. Qi, Haihai Liang, 2021, Computational and structural biotechnology journal.

An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering

Yunyan Gu, Wenyuan Zhao, Yan Xu, 2020, Aging.

RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome

Yunyan Gu, Zhangxiang Zhao, Qi Dong, 2019, Database J. Biol. Databases Curation.

Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer

Xia Li, Yunyan Gu, Min Zou, 2021, iScience.

Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells

Tingting Chen, Yunyan Gu, Zhangxiang Zhao, 2019, Molecular therapy. Nucleic acids.

Pan‐cancer multi‐omics analyses reveal crosstalk between the Hippo and immune signaling pathways in the tumor microenvironment

Ting Chen, Tong Zhu, Yunyan Gu, 2021, FEBS letters.

Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells

Yunyan Gu, Yang Hui, Zhangxiang Zhao, 2023, British Journal of Cancer.

Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway

Yunyan Gu, Haihai Liang, Tong Yu, 2023, JCI insight.

Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2024, Cancer letters.

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2024, World journal of surgical oncology.

Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2023, Computational and structural biotechnology journal.

Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level

Yunyan Gu, Tongzhu Jin, Zhangxiang Zhao, 2023, Cell cycle.

Single-cell landscape of intratumoral heterogeneity and tumor microenvironment remolding in pre-nodal metastases of breast cancer

Yunyan Gu, Kaidong Liu, Bo Chen, 2024, Journal of translational medicine.